Non-prescription medicines and Australian community pharmacy interventions: Rates and clinical significance

International Journal of Pharmacy Practice

Volumn 19, Issue 3, 2011, Pages 156-165

  Williams, Kylie A ^a   Emmerton, Lynne M ^b   Taylor, Richard ^c   Werner, Joel ^a   Benrimoj, Shalom Isaac ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Australia; community pharmacy; drug related problems; interventions; non prescription; over the counter

Indexed keywords

NON PRESCRIPTION DRUG;

ARTICLE; AUSTRALIA; DRUG USE; HARM REDUCTION; HUMAN; INCIDENCE; NORMAL HUMAN; PHARMACIST; PHARMACY; PRIORITY JOURNAL;

ADULT; AUSTRALIA; COMMUNITY PHARMACY SERVICES; FEMALE; HUMANS; MALE; NONPRESCRIPTION DRUGS; PROFESSIONAL ROLE;

EID: 79955903652     PISSN: 09617671     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7174.2010.00091.x     Document Type: Article

References (33)

1. Blenkinsopp A, Bradley C,. Over the counter drugs: patients, society and the increase in self medication. Br Med J 1996; 312: 629-632. (Pubitemid 26079605)
2. Soller RW,. Evolution of self-care with over-the-counter medications. Clin Ther 1998; 20 (Suppl. 3): C134-C140.
3. Charupatanapong N,. Perceived likelihood of risks in self-medication practices. J Soc Adm Pharm 1994; 11: 18-28. (Pubitemid 24192415)
4. Brass EP,. Changing the status of drugs from prescription to over-the-counter availability. N Engl J Med 2001; 345: 810-816.
5. International Pharmaceutical Federation. Standards for Quality of Pharmacy Services. The Hague: International Pharmaceutical Federation, 1997: (accessed 6 July 2010).
6. Pharmaceutical Society of Australia. Standards for the Provision of Pharmacy Medicines and Pharmacist Only Medicines in Community Pharmacy. Canberra: Pharmaceutical Society of Australia, 2005.
7. Pharmaceutical Society of Australia. Competency Standards for Pharmacists in Australia. Canberra: Pharmaceutical Society of Australia, 2003.
8. NSW Health, Pharmaceutical Services Branch. Guide to Poisons and Therapeutic Goods Legislation for Pharmacists. January 2009. (accessed 6 July 2010).
9. Gilbert A, et al,. A review of pharmaceutical scheduling processes in six countries and the effect on consumer access to medicines. Int J Pharm Prac 2006; 14: 95-104. (Pubitemid 43799502)
10. Galbally R,. National Competition Review of Drugs, Poisons and Controlled Substances Legislation: Final Report Part A. Woden: Commonwealth of Australia, 2000: (accessed 6 July 2010).
11. Dooley MJ, et al,. A prospective multicentre study of pharmacist initiated changes to drug therapy and patient management in acute care government funded hospitals. Br J Clin Pharmacol 2004; 57: 513-521. (Pubitemid 38519658)
12. Parthasarathi G, et al,. Assessment of drug-related problems and clinical pharmacists' interventions in an Indian teaching hospital. J Pharm Pract Res 2003; 33: 272-274. (Pubitemid 38035969)
13. Leemans L, et al,. Frequency and trends of interventions of prescriptions in Flemish community pharmacies. Pharm World Sci 2003; 25: 65-69. (Pubitemid 36547115)
14. Benrimoj SI, et al,. Clinical intervention rates in community pharmacy: a randomised trial of the effect of education and a professional allowance. Int J Pharm Prac 2003; 11: 71-80. (Pubitemid 36790929)
15. Norris P,. Purchasing restricted medicines in New Zealand pharmacies: results from a 'mystery shopper' study. Pharm World Sci 2002; 24: 149-153. (Pubitemid 34951314)
16. Rutter PM, et al,. Evaluation of community pharmacists' recommendations to standardized patient scenarios. Ann Pharmacother 2004; 38: 1080-1085. (Pubitemid 38657756)
17. Alte D, et al,. Evaluation of consultation in community pharmacies with mystery shoppers. Ann Pharmacother 2007; 41: 1023-1030. (Pubitemid 46917630)
18. Benrimoj SI, et al,. Monitoring quality standards in the provision of non-prescription medicines from Australian community pharmacies: results of a national programme. Qual Saf Health Care 2007; 16: 354-358. (Pubitemid 47612674)
19. Benrimoj SI, et al,. A system for monitoring quality standards in the provision of non-prescription medicines from Australian community pharmacies. Pharm World Sci 2008; 30: 147-153. (Pubitemid 351311414)
20. Taylor JG, et al,. Assisting consumers with their OTC choices. CPJ 2006; 139: 38-45.
21. Sclar DA, et al,. Pharmacy consultation and over-the-counter medication purchasing outcomes. J Clin Pharm Ther 1996; 21: 177-184. (Pubitemid 26273777)
22. Guignard AP, et al,. Economic impact of pharmacists' interventions with nonsteroidal antiinflammatory drugs. Ann Pharmacother 2003; 37: 332-338. (Pubitemid 36249629)
23. Westerlund T, et al,. Evaluation of a model for counseling patients with dyspepsia in Swedish community pharmacies. Am J Health Syst Pharm 2003; 60: 1336-1341. (Pubitemid 46118104)
24. Viktil KK, et al,. Comparison of drug-related problems in different patient groups. Ann Pharmacother 2004; 38: 942-948. (Pubitemid 38657731)
25. Ernst ME, et al,. Drug-related problems and quality of life in arthritis and low back pain sufferers. Value Health 2003; 6: 51-58. (Pubitemid 36228349)
26. Vinks THAM, et al,. Identification of potential drug-related problems in the elderly: the role of the community pharmacist. Pharm World Sci 2006; 28: 33-38. (Pubitemid 44198336)
27. Alderman CP, Farmer C,. A brief analysis of clinical pharmacy interventions undertaken in an Australian teaching hospital. J Qual Clin Prac 2001; 21: 99-103. (Pubitemid 34139816)
28. Dreyer AC, et al,. Cost savings effected by community pharmacists' interventions in the supply of medicines in the Republic of South Africa. J Res Pharm Econ 1999; 9: 1-20. (Pubitemid 29481889)
29. Westerlund LOT, et al,. Nonprescription drug-related problems and pharmacy interventions. Ann Pharmacother 2001; 35: 1343-1349. (Pubitemid 33042064)
30. Gray S, et al,. Evaluating the potential impact of community pharmacy interventions on patient care in Northumberland. Qual Prim Care 2004; 12: 47-51. (Pubitemid 38461327)
31. Hammerlein A, et al,. Survey of drug-related problems identified by community pharmacies. Ann Pharmacother 2007; 41: 1825-1832. (Pubitemid 350044345)
32. Benrimoj SI, et al,. A Cost-Benefit Analysis of Pharmacist-Only (S3) and Pharmacy Medicines (S2) and Risk-Based Evaluation of the Standards. Final Report-Appendices. Sydney: The University of Sydney. June 2005. (accessed 6 July 2010).
33. The Pharmacy Guild of Australia. Quality Care Pharmacy Program. (accessed 6 July 2010).